Doyle Mittie sold AVTX
March 16, 2026 · Form 4 insider transaction
Doyle Mittie sold 25,492 shares of Avalo Therapeutics, Inc. at $16.15 per share, a transaction worth $411.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
25,492
Price
$16.15
Total value
$411.6K
InsiderDoyle Mittie
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 18, 2026
Shares owned after3,622
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were sold in multiple transactions at prices ranging from $16.00 to $16.34. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.